|
Promotor
|
A.G. Uitterlinden (André)
,
J.B.J. van Meurs (Joyce)
|
|
Publisher
|
Erasmus University Rotterdam
|
|
Sponsor
|
Financial support for the publication of this thesis was kindly provided by the Erasmus University Rotterdam, the Anna Foundation (Anna Fonds), Stichting Artrose Zorg, Pfizer, and Becton Dickinson (BD).
|
|
ISBN
|
978-94-028-0061-6
|
|
Persistent URL
|
hdl.handle.net/1765/79902
|
|
Note
|
The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMW); the Research Institute for Diseases in the Elderly (RIDE); the Dutch Ministry of Education, Culture and Science; the Dutch Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.
Additional funding for the work described in this thesis was provided by the European Commission (HEALTH-F2-2008-201865, GEFOS; HEALTH-F2-2008 35627, TREAT-OA); Netherlands Organisation for Scientific Research (NWO) Investments (nr. 175.010.2005.011, 911-03-012); the Netherlands Consortium for Healthy Ageing (NCHA); the Netherlands Genomics Initiative (NGI) / Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810; and Vidi grant 917103521.
The infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute grant R01HL105756.
|
|
Grant
|
This work was funded by the European Commission 7th Framework Programme; grant id fp7/603288 - Systems Biology to Identify Molecular Targets for Vascular Disease Treatment (SYSVASC),
This work was funded by the European Commission 7th Framework Programme; grant id fp7/261433 - Biobank Standardisation and Harmonisation for Research Excellence in the European Union (BIOSHARE-EU)
|
|
Organisation
|
Erasmus MC: University Medical Center Rotterdam
|
